| |
| |
|
| Insider
Information: |
Bozigian Haig P. |
| Relationship: |
Chief Development Offi... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
157,651 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$21,976,549 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
157,651 |
|
|
| Total
Value |
$21,976,549 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neurocrine Biosciences Inc |
NBIX |
Chief Development Offi... |
2021-02-08 |
157,651 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
92 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2016-02-03 |
4 |
AS |
$38.13 |
$52,429 |
D/D |
(1,375) |
111,454 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2017-01-10 |
4 |
AS |
$43.37 |
$70,476 |
D/D |
(1,625) |
113,079 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2017-01-17 |
4 |
AS |
$40.63 |
$66,024 |
D/D |
(1,625) |
114,704 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2017-02-03 |
4 |
AS |
$42.57 |
$58,534 |
D/D |
(1,375) |
116,079 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2017-02-06 |
4 |
AS |
$43.14 |
$41,544 |
D/D |
(963) |
117,666 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2017-04-12 |
4 |
AS |
$50.41 |
$658,774 |
D/D |
(13,065) |
129,601 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2017-08-04 |
4 |
OE |
$5.76 |
$317,200 |
D/D |
45,000 |
149,601 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2017-08-04 |
4 |
AS |
$50.00 |
$1,125,000 |
D/D |
(22,500) |
129,601 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2017-09-06 |
4 |
OE |
$8.65 |
$350,138 |
D/D |
26,250 |
140,851 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2017-09-06 |
4 |
AS |
$60.00 |
$1,575,000 |
D/D |
(26,250) |
129,601 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2018-01-16 |
4 |
AS |
$79.12 |
$128,575 |
D/D |
(1,625) |
131,226 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2018-02-05 |
4 |
AS |
$83.02 |
$187,977 |
D/D |
(2,262) |
134,264 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2018-02-06 |
4 |
D |
$82.48 |
$75,634 |
D/D |
(917) |
135,997 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2018-03-05 |
4 |
AS |
$90.00 |
$6,828,570 |
D/D |
(75,873) |
135,997 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2018-03-05 |
4 |
OE |
$5.76 |
$976,703 |
D/D |
75,873 |
150,396 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2018-11-06 |
4 |
OE |
$35.99 |
$339,026 |
D/D |
9,420 |
145,417 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2018-11-06 |
4 |
AS |
$110.10 |
$1,037,167 |
D/D |
(9,420) |
135,997 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2018-11-07 |
4 |
AS |
$110.00 |
$3,238,132 |
D/D |
(29,399) |
135,997 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2018-11-07 |
4 |
OE |
$5.76 |
$371,105 |
D/D |
29,399 |
151,043 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2018-11-08 |
4 |
AS |
$110.00 |
$3,992,450 |
D/D |
(36,295) |
135,997 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2018-11-08 |
4 |
OE |
$8.65 |
$314,147 |
D/D |
36,295 |
152,791 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-02-04 |
4 |
AS |
$88.10 |
$121,139 |
D/D |
(1,375) |
137,372 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-02-05 |
4 |
AS |
$88.06 |
$118,986 |
D/D |
(1,350) |
139,909 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-02-06 |
4 |
AS |
$83.54 |
$76,859 |
D/D |
(920) |
141,639 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-05-13 |
4 |
AS |
$75.51 |
$2,608,813 |
D/D |
(34,547) |
141,976 |
0 |
- |
|
92 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
